Research programme: DNA vaccines - Coridon

Drug Profile

Research programme: DNA vaccines - Coridon

Alternative Names: EBV vaccine - Coridon; Epstein Barr Virus vaccine - Coridon; HPV vaccine - Admedus; HPV vaccine - Allied Healthcare Group; HPV vaccine - Coridon; Human papillomavirus vaccine - Coridon

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Queensland
  • Developer Admedus
  • Class Cancer vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Epstein-Barr virus infections; Lymphoma
  • No development reported Cervical cancer; Human papillomavirus infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in Australia (Parenteral, Injection)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Cervical-cancer(Prevention) in Australia (Parenteral, Injection)
  • 01 Jan 2014 Early research in Epstein-Barr virus infections in Australia (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top